Loading...
•
Mar 31, 2020
Exact Sciences Q1 2020 Earnings Report
Exact Sciences announced first quarter 2020 results with revenue of $347.8 million.
Key Takeaways
Exact Sciences Corp. reported revenue of $347.8 million for the first quarter ended March 31, 2020, compared to $162.0 million for the same period of 2019. The company's screening revenue was $219.5 million, an increase of 35 percent, while precision oncology revenue was $128.4 million. The net loss was $105.7 million, or $0.71 per share.
Total revenue was $347.8 million, compared to $162.0 million.
Screening revenue was $219.5 million, an increase of 35 percent.
Precision Oncology revenue was $128.4 million.
Net loss was $105.7 million, or $0.71 per share.
Revenue by Segment
Forward Guidance
Exact Sciences plans to play an even greater role in cancer screening and guiding therapy decisions after the coronavirus pandemic abates.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...